-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

632. Chronic Myeloid Leukemia: Therapy: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Monday, December 3, 2018: 6:00 PM-8:00 PM
Hall GH (San Diego Convention Center)

Nicholas L Jackson Chornenki, BSc1, Christopher M. Hillis, MD2, Isabelle Bence-Bruckler, MD3*, Lambert Busque, MD4, Caroline Hamm, MD5, Wanda Hasegawa, MD6*, Jeffrey H. Lipton, MD, PhD7, Lynn Savoie, MD8*, Robert Turner, MD9*, Anargyros Xenocostas, MD10, Suzanne Kamel-Reid, BA, MA, PhD, FACMG11 and Brian Leber, MD1

1McMaster University, Hamilton, ON, Canada
2Juravinski Cancer Centre, Hamilton, ON, CAN
3University of Ottawa Blood Disease Centre, Ottawa, Canada
4Department of Medicine, University of Montreal, Montreal, QC, Canada
5Windsor Regional Cancer Center, Windsor, ON, Canada
6QEII, Dalhousie University, Halifax, NS, Canada
7Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
8University of Calgary, Calgary, AB, Canada
9University of Alberta, Edmonton, Canada
10Schulich School of Medicine, London, Canada
11Advanced Molecular Diagnostics Laboratory, UHN, Toronto, ON, Canada

Michele Malagola, MD1, Fabio Efficace, PhD2*, Nicola Polverelli, MD3*, Elisabetta Abruzzese4, Alessandra Iurlo5*, Cristina Bucelli, MD6*, Fabio Stagno, MD, PhD7, Massimiliano Bonifacio8*, Mariella D'adda, MD9*, Monia Lunghi10*, Monica Crugnola, MD11*, Francesca Lunghi12*, Fausto Castagnetti13, Gianantonio Rosti14*, Ferrari Maria Luisa15*, Micaela Bergamaschi, MD16*, Gianni Binotto, MD17*, Rosaria Sancetta, MD18*, Maria Rosaria Coppi19*, Valentina Giai20*, Giovanna Rege Cambrin, MD21*, Atelda Romano, MD22*, Mario Tiribelli23*, Sabina Russo24*, Lara Aprile25*, Antonietta Pia Falcone, MD26*, Serena Rupoli, MD27*, Antonella Russo Rossi, MD28*, Emilio Usala, MD29*, Bruno Martino, MD30*, Lisa Gandolfi3*, Simona Bernardi, PhD3*, Camilla Zanaglio, PhD3*, Mirko Farina, MD3*, Michele Baccarani, MD31 and Domenico Russo, MD3

1Bone Marrow Transplant Unit, ASST-Spedali Civili di Brescia, Spedali Civili, Brescia, Italy
2Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy
3Bone Marrow Transplant Unit, ASST-Spedali Civili di Brescia, Chair of Hematology, Dpt of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
4Hematology, S.Eugenio Hospital, Roma, Italy
5Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
6Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, and University of Milan, Milano, Italy
7Hematology Unit, Hematology Section, Biomedical Sciences, Trecastagni, Catania, Italy
8Department of Medicine, Section of Haematology, Verona University, Verona, Italy
9Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
10AOU “Maggiore della Carità", SCDU Ematologia, Novara, ITA
11Department of Medicine and Surgery, University of Parma, Parma, Italy
12Haematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute IRCCS, Milano, Italy
13Institute of Hematology "L. e A. Seràgnoli", DIMES, University of Bologna, Bologna, Italy
14Institute of Hematology "L. and A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, Bologna, Italy
15ASST Papa Giovanni XXIII, Hematology and Bone Marrow Transplant Unit, Bergamo, Jamaica
16Division of Hematology, University of Genoa, Opsedale policlinico San Martino, IRCCS per l'Oncologia, Dipartment of Internal Medicine, Genova, Italy
17Hematology and Clinical Immunology, Department of Medicine, Padua School of Medicine, Padova, Italy
18Hematology Unit, Ospedale dell'Angelo Mestre, Venezia, Italy
19"Antonio Perrino" Hospital, Haematology and BMT Unit, Brindisi, Italy
20Ospedale SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
21University of Turin, ORBASSANO TORINO, ITA
22Hematology, Istituto Nazionale Tumori Regina Elena - IFO, Rome, Italy
23Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy
24Dipartimento di Medicina Interna, AOU Policlinico di Messina, Messina, Italy
25Hematology, University of Siena, Siena, Italy
26IRCCS "Casa Sollievo della Sofferenza", Hematology Unit, San Giovanni Rotondo, Italy
27Hematology Unit, AOU- Ospedali Riuniti Umberto I, Ancona, Italy
28Hematology, University of Bari, Bari, ITA
29Hematology and Bone Marrow Transplantation Unit, Ospedale Oncologico di Riferimento Regionale "Armando Businco", Cagliari, Italy
30Azienda Ospedaliera "Bianchi Melacrino Morelli", Reggio Calabria, Italy
31Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Institute of Hematology and Medical Oncology "L. & A. Seràgnoli", Bologna, Italy

Dae Young Zang, MD, PhD1*, Won Sik Lee, MD, PhD2, Yeung-Chul Mun3*, Young Rok Do, PhD, MD4, Sukjoong Oh, MD, PhD5, Sung-Eun Lee, MD, PhD6*, Soo Young Choi7* and Dong-Wook Kim, MD, PhD8

1Department of Internal Medicine, Hallym University College of Medicine, Hallym University Sacred Heart Hospital, Anyang-Si, Korea, Republic of (South)
2Inje University College of Medicine, Inje University Busan Paik Hospital, Busan, Korea, Republic of (South)
3Department of Hematology, Ewha Womans University, Seoul, Korea, Republic of (South)
4Department of Internal Medicine, Dongsan Medical Center Keimyung University, Daegu, Korea, Republic of (South)
5Division of Hematology-Oncology, Kangbuk Samsung Hospital, Seoul, Korea, Republic of (South)
6Department of Hematology, Catholic Hematology Hospital, Seoul, Korea, Republic of (South)
7Leukemia Research Institute, The Catholic University of Korea, Seoul, South Korea
8Department of Hematology, Seoul St. Mary's Hospital The Catholic University of Korea, Seoul, South Korea

Neil P. Shah, MD, PhD1, Jose Valentín García Gutiérrez, MD. PhD2, Antonio Jiménez-Velasco, MD3*, Sarah Larson, MD4*, Susanne Saussele, MD 5, Delphine Rea, MD6, François-Xavier Mahon, MD, PhD7, Moshe Yair Levy, MD8, María Teresa Gómez-Casares, MD, PhD9*, Fabrizio Pane, MD10*, Franck-Emmanuel Nicolini, MD, PhD11, Michael J. Mauro, MD12, Oumar Sy, PhD13*, Patricia Martin Regueira13* and Jeffrey H. Lipton, MD, PhD14

1Department of Medicine/Hematology-Oncology, UCSF School of Medicine, San Francisco, CA
2Servicio Hematologia y Hemoterapia, Hospital Universitario Ramon y Cajal, Madrid, Spain
3Hospital Universitario Carlos Haya, Malaga, Spain
4David Geffen School of Medicine at UCLA, Los Angeles, CA
5Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany
6Hôpital Saint-Louis, Paris, France
7Hématologie, Université Bordeaux Segalen, Bordeaux, France
8Baylor Charles A. Sammons Cancer Center, Dallas, TX
9Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain
10Università degli Studi di Napoli Federico II, Naples, Italy
11Hématologie clinique, Centre Léon Bérard, Lyon, France
12Myeloproliferative Neoplasms Program, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
13Bristol-Myers Squibb, Princeton, NJ
14Cancer Clinical Research Unit, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

Ekaterina Chelysheva, MD, PhD1*, Jane Apperley, MB ChB MD2, Elisabetta Abruzzese3, Dong-Wook Kim, MD, PhD4, Konstantin Kotlyarchuk5*, Oleg Shukhov, MD, PhD1* and Anna G Turkina, Prof., MD1

1National Research Center for Hematology, Moscow, Russian Federation
2Centre for Haematology, Imperial College London, London, United Kingdom
3Hematology Unit, S. Eugenio Hospital, Roma, Italy
4Department of Hematology, Seoul St. Mary's Hospital The Catholic University of Korea, Seoul, South Korea
5SI 'Institute of Blood Pathology and Transfusion Medicine UAMS, Lviv, Ukraine

Ekaterina Chelysheva, MD, PhD1*, Elisabetta Abruzzese2, Delphine Rea, MD3, Dong-Wook Kim, MD, PhD4, Khamida Kazakbaeva, MD5*, Sukhrob Saliev5*, Konstantin Kotlyarchuk6*, Evgenia Polushkina7*, Roman Shmakov, MD, PhD7*, Julia Chabaeva8*, Sergei M. Kulikov, PhD8* and Anna G Turkina, Prof., MD8

1National Research Center for Hematology, Moscow, AZ
2Hematology Unit, S. Eugenio Hospital, Roma, Italy
3Adult Hematology department, Hôpital Saint-Louis, Paris, France
4Department of Hematology, Seoul St. Mary's Hospital The Catholic University of Korea, Seoul, South Korea
5Research Institute of Hematology and Blood Transfusion MOH of Uzbekistan, Tashkent, Uzbekistan
6SI 'Institute of Blood Pathology and Transfusion Medicine UAMS, Lviv, Ukraine
7National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russian Federation
8National Research Center for Hematology, Moscow, Russian Federation

Francesco Malaspina, MD1*, Maria Caterina Putti, MD2*, Michelina Santopietro, MD1*, Saverio Ladogana, MD3*, Rosamaria Mura, MD4*, Roberta Burnelli, MD5*, Nadia Vacca, MD6*, Lorenzo Rizzo1*, Maria Luisa Moleti, MD1*, Anna Maria Testi, MD1*, Andrea Biondi7, Franco Locatelli8, Giuseppe Saglio9, Robin Foà, MD1 and Fiorina Giona, MD1

1Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy
2Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Padova, Padova, Italy
3Department of Pediatrics, "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, Italy
4Pediatric Hemato-Oncology Unit, Ospedale Regionale per le Microcitemie, Cagliari, Italy
5Pediatric Hemato-Oncology Unit, Sant'Anna Hospital, Ferrara, Italy
6Pediatric Unit, Ospedale di Sassari, Sassari, Italy
7University of Milano-Bicocca, Department of Pediatrics, San Gerardo Hospital/Fondazione MBBM, Tettamanti Research Center, Monza (MB), Italy
8Department of Hematology/Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children’s Hospital, Rome, Italy
9Department of Clinical and Biological Sciences, University of Turin, Orbassano, Turin, Italy

Shady Awad, MD1*, Matti Kankainen, PhD2*, Olli Dufva1*, Caroline A Heckman, PhD3, Kimmo Porkka, MD, PhD1 and Satu Mustjoki, MD, PhD4

1Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
2Institute for Molecular Medicine Finland (FIMM), HILIFE, Helsinki, Finland
3Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
4Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

Michael J. Mauro, MD1, Clara Chen, PhD, BS, MS2*, Jorge E. Cortes, MD3, Carlo Gambacorti-Passerini, MD4, Ginny P Sen, MPH5*, Srikanth Gajavelli, MD2*, Catherine Davis2* and Mauricette Michallet, MD, PhD6

1Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Bristol-Myers Squibb, Princeton, NJ
3Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
4University Milano Bicocca, San Gerardo Hospital, Monza, Italy
5ICON Clinical Research LLC, South San Francisco, CA
6Hematology, Centre Leon Berard, Lyon, France

Onyee Chan, MD1, Chetasi Talati, MD2, Leidy Isenalumhe, MD2, Michael Fradley, MD3*, Samantha Shams, MD1, Javier Pinilla Ibarz, MD4 and Kendra L. Sweet, MD5

1Moffitt Cancer Center/University of South Florida, Tampa, FL
2Division of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
3Cardio-Oncology Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
4Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa , FL
5Malignant Hematology Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Henrik Hjorth-Hansen, MD1, Satu Mustjoki, MD, PhD2, Ulla Olsson-Strömberg, MD, PhD3*, Jesper Stentoft, Professor, dr.med.4*, Fabio Efficace, PhD5*, Hemming Johansson, PhD6* and Yvonne Brandberg, PhD6*

1Department of Hematology, St Olavs Hospital, Trondheim, Norway
2Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
3Department of Hematology, University Hospital Uppsala, Uppsala, Sweden
4Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
5Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy
6Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden

Bora Nam, MBA, PhD1*, Soktae Kim, MBA, PhD1*, Jae Hoon Lee, MD, PhD2, Kwai Han Yoo, MD2*, Jeong-Yeal Ahn, MD3* and Hawk Kim, MD, PhD2

1Department of International Trade, Dongguk University, Seoul, Korea, Republic of (South)
2Division of Hematology, Gachon University Gil Medical Center, Incheon, Korea, Republic of (South)
3Department of Laboratory Medicine, Gachon University Gil Medical Center, Incheon, Korea, Republic of (South)

Jee Hyun Kong, MD1*, Tae-Hwa Go2*, Jung Yeon Lee, M.D.1*, Jieun Uhm, MD, PhD3 and Shin Young Hyun, MD1*

1Division of Hematology-oncology, Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University College of Medicine, Wonju, Korea, Republic of (South)
2Center of Biomedical Data Science, Wonju Severance Christian Hospital, Yonsei University College of Medicine, Wonju, Korea, Republic of (South)
3Division of Hematology and Oncology, Department of Internal Medicine, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, Korea, Republic of (South)

Jeong-Ok Lee, MD1, Dong-Wook Kim, MD, PhD2, Elisabetta Abruzzese, MD3, Jane Apperley, MB ChB MD4, Louise Caldwell, BSc5* and Michael J. Mauro, MD6

1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, Republic of (South)
2Department of Hematology, Catholic Blood and Marrow Transplantation Center, Leukemia Research Institute, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Haematology Unit, S. Eugenio Hospital, Rome, Italy
4Centre for Haematology, Imperial College London, London, United Kingdom
5Medical School, University of Birmingham, Sheffield, United Kingdom
6Myeloproliferative Neoplasms Program, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

Tim H Brümmendorf, MD1, Carla M. Mamolo, PhD2*, Arlene Reisman3*, Andrew G Bushmakin2*, Joseph C Cappelleri, PhD, MPH, MS2*, Rocco J. Crescenzo, DO, FACOI4*, Liza DeAnnuntis4*, Andrea Viquiera5* and Jorge E. Cortes, MD6

1Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Universitätsklinikum RWTH, Aachen, Germany
2Pfizer Inc, Groton, CT
3Pfizer Inc, New York, NY
4Pfizer Inc, Collegeville, PA
5Pfizer SLU, Madrid, Spain
6Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Elias J. Jabbour, MD1, Min You, MS2*, Trong Kim Le, MPH, MS2*, John Brokars, MS2*, Alexander Brun, PharmD2* and Dinara Makenbaeva, MD, MBA2*

1University of Texas, MD Anderson Cancer Center, Houston, TX
2Bristol-Myers Squibb, Princeton, NJ

Maria Gemelli, MD1,2*, Chiara Elena, MD3*, Margherita Maffioli, MD4*, Cristina Bucelli, MD5*, Marianna Rossi, MD6*, Mattia Bacciocchi7*, Elena Maria Elli, MD8*, Maria Grazia Valsecchi, PhD9*, Laura Antolini, PhD10* and Carlo Gambacorti-Passerini, MD7,11

1Medical Oncology Division, Ospedale San Gerardo-ASST-Monza, Monza, Italy
2Università degli Studi di Milano, Monza, Monza-Brianza, Italy, Italy
3Department of Hematology Oncology, Foundation IRCCS Policlinico San Matteo, Pavia, Italy
4Hematology, Department of Medicine and Surgery, Ospedale di Circolo, ASST Sette Laghi, Varese, Italy
5Hematology Division, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, ITA
6Cancer Center - IRCCS Humanitas Research Hospital & Humanitas University, Rozzano - Milan, Italy
7Università degli Studi di Milano- Bicocca, Monza, Italy
8Hematology Division, Ospedale San Gerardo - ASST Monza, Monza, Italy
9Universita' Degli Studi Di Milano-Bicocca, Center of Biostatistics for Clinical Epidemiology, School of Medicine and Surgery, Monza, Italy
10Università degli Studi di MIlano- Bicocca, Monza, Italy
11Hematology Division, Ospedale San Gerardo- ASST Monza, Monza, Italy

Pongtep Viboonjuntra, M.D., Ph.D.1*, Arnuparp Lekhakula, M.D., M.S.1*, Kanchana Chansung, MD2*, Chittima Sirijerachai, M.D.2*, Pimjai Niparuck, MD3*, Teeraya Pauvilai, M.D.3*, Tontanai Numbenjapon, MD4*, Udomsak Bunworasate, M.D.5*, Weerasak Nawarawong, MD6*, Adisak Tantiworawit, MD 7, Tawatchai Suwanban, M.D.8* and Saengsuree Jootar, MD3*

1Division of Clinical Hematology, Department of Internal Medicine, Prince of Songkla University, Hatyai, Songkhla, Thailand
2Division of Hematology, Department of Internal Medicine, Khonkaen University, Khonkaen, Thailand
3Division of Hematology, Department of Internal Medicine, Ramathibodi Hospital, Bangkok, Thailand
4Division of Hematology, Department of Internal Medicine, Phramongkutklao Hospital, Bangkok, Thailand
5Division of Hematology, Department of Internal Medicine, Chulalongkorn University, Bangkok, Thailand
6Division of Hematology, Department of Internal Medicine, Chiangmai University, Chiangmai, Thailand
7Division of Hematology, Department of Internal Medicine, Chiang Mai University, Muang, Chiang Mai, Thailand
8Division of Hematology, Department of Internal Medicine, Rajavithi Hospital, Bangkok, Thailand

Noriyoshi Iriyama, MD, PhD1*, Kei-Ji Sugimoto2*, Eriko Sato, MD, PhD3*, Tomoiku Takaku, MD, PhD4, Michihide Tokuhira5*, Tomonori Nakazato, MD, PhD6, Maho Ishikawa, MD7*, Hiroyuki Fujita, MD8, Yuta Kimura, MD9*, Isao Fujioka, MD4*, Norio Asou, MD, Ph.D10, Masahiro Kizaki, MD, PhD11, Norio Komatsu, MD, PhD12, Yoshihiro Hatta, MD, PhD13 and Tatsuya Kawaguchi, MD, PhD14

1Nihon University, Tokyo, Japan
2Department of Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan
3Department of Hematology, Juntendo University Nerima Hospital, Tokyo, Japan
4Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan
5Department of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan
6Department of Hematology, Yokohama Municipal Citizen's Hospital, Tokyo, Japan
7Department of Hemato-Oncology, Comprehensive Cancer Center, Saitama Medical University International Medical Center, Saitama, Japan
8Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan
9Departments of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan
10Saitama Medical University, International Medical Center, Hidaka, Saitama, Japan
11Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan
12Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan
13Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan
14Department of Medical Technology, Kumamoto Health Science University, Kumamoto, Japan

Seema S. Bhatwadekar, MD1 and Parth Shah, MD2

1Haemato-oncology Care Centre,, Vadodara, IND
2Department of Hematology and Oncology, Dartmouth Hitchcock Medical Center, Lebanon, NH

Jun Kong, MD1*, Xiao-Hong Liu2*, Ya-Zhen Qin3*, Hong-Xia Shi2*, Yue-Yun Lai4*, Xiao-Jun Huang3 and Hao Jiang3*

1Institute of Hematology, Peking University People,s Hospital, Beijing, China
2Peking University People,s Hospital, Bei jing, China
3Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
4Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China

Akiko Mita, MD1*, Maiko Abumiya, PhD2*, Saori Takahashi, Ms3*, Yoshihiro Kameoka, MD, PhD3,4*, Masatomo Miura, PhD2* and Naoto Takahashi, MD4

1Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan
2Department of Pharmacy, Akita University Hospital, Akita, Japan
3Clinical Research Promotion and Support Center, Akita University Hospital, Akita, Japan
4Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan

Jingying Dai, PhD1*, Xi Yang2*, Xiaobing Huang1*, Hong Zheng, MD, PhD3 and Xiaodong WANG, MD4*

1Department of Hematology, Sichuan Provincial People's Hospital; Affiliated Hospital of University of Electronic Science and Technology of China, Chengdu, China
2Department of Hematology, Sichuan Provincial People’s Hospital, Affliated Hospital of University of Electronic Science and Technology of China, Chengdu, Sichuan, China
3Penn State Cancer Institute, Penn State Hershey Medical Center, Hershey, PA
4Sichuan Provincial People’s Hospital, Affliated Hospital of University of Electronic Science and Technology of China, Chengdu, CHN

Laura Spatafora1*, Breanne Golemiec2,3*, Lehana Thabane, Ph.D.4*, Laura Banfield5*, Christopher M. Hillis, MD6, Constantine Samaan, MD7* and Uma Athale, MD, MBBS, MSc8

1Pediatrics, Michael G DeGroot School of Medicine, Hamilton, ON, Canada
2Pediatrics, Michael DeGroot School of Medicine, McMaster University, Hamilton, Canada
3Pediatrics, Michael G DeGroot School of Medicine, McMaster University, Ontario, Canada
4Department of Health Research Methods, Evidence and Impact, McMaster University, Ontario, Canada
5Health Sciences Library, McMaster University, Hamilton, Canada
6Juravinski Cancer Centre, Hamilton, ON, CAN
7Pediatrics, McMaster University, Hamilton, Canada
8McMaster Children's Hospital, McMaster University Div. of Pediatric Hematology/Oncology, Hamilton, ON, Canada

Tomas Radivoyevitch1*, Brian P. Hobbs, PhD2* and Jaroslaw P. Maciejewski3

1Departments of Quantitative Health Sciences and Translational Hematology and Oncology Research, Quantitative Health Sciences, Cleveland, OH
2Cancer Biostatistics, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
3Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

Kai Sun, MD1, Xuejun Zhang, M.D.2*, Zhen Wang, M.D.3*, Yuqing Chen, M.D.3*, Lei Zhang, M.D.4*, Wei Cheng, M.D.4*, Mingyue Shi, M.D.3*, Lei Huo, M.D.3*, Yanliang Bai, M.D.3*, Xiaona Niu, M.D.3*, Honggang Guo, M.D.3*, Jing Yang, M.D.3*, Chunrong Tong, M.D.5* and AlexH Chang, M.D., Ph.D.6*

1Department of Hematology, Zhengzhou Univsersity People's Hospital & Henan Provincial, Zhengzhou, Henan, China
2Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China
3Department of Hematology, Zhengzhou University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, China
4Institute of Hematology, Zhengzhou University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, China
5Department of Hematology, Beijing Boren Hospital, Beijing, China
6Clinical Translational Research Center, Shanghai Pulmonary Hospital,Tongji University School of Medicine, Beijing, China

Uttam Kumar Nath, MD, DM1, Rituparna Chetia, MD2* and Avriti Baveja, MD2*

1Department of Hematology, All India Institute of Medical Sciences (AIIMS), Rishikesh, All India Institute of Medical Sciences (AIIMS), Rishikesh, Rishikesh, India
2Department of Hematology, All India Institute of Medical Sciences (AIIMS) Rishikesh, Rishikesh, India

*signifies non-member of ASH